Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this case study, a female patient with alopecia areata experienced significant symptom reduction after Ayurvedic treatments including Nasya and Pracchanna karma, suggesting potential effectiveness of this approach for managing autoimmune hair disorders.

In this case study, a female patient with alopecia areata experienced significant symptom reduction following Ayurvedic treatment, including Nasya and Pracchanna karma, suggesting potential benefits of Ayurveda for autoimmune hair disorders.

This case study reports significant hair regrowth in a patient with alopecia areata using Ayurvedic treatments, which included Nasya with Bindu Taila, Pracchan Karma, and topical therapies with castor leaves and buffalo butter, without causing adverse effects.

This source describes alopecia areata as a long-term, immune-mediated disorder causing non-scarring hair loss, often starting in childhood or early adulthood due to genetic predisposition and an immunological attack on hair follicles.

This case report documents a successful treatment of alopecia areata using Ayurvedic management, suggesting that Ayurveda could help restore balance and promote hair regrowth in this autoimmune condition.

This case report describes the successful treatment of alopecia areata using Ayurvedic management, suggesting that Ayurveda may aid in rebalancing the body and promoting hair regrowth in autoimmune conditions.

This study identified specific genes upregulated in skin γδ T cells involved in alopecia areata, with findings suggesting these cells contribute to disease pathogenesis through inflammatory and Th1 response mechanisms in mouse and possibly human skin.

This study reviewed Ayurvedic texts and concepts related to hair loss, known as Indralupta, its pathogenesis involving vitiated doshas and blood, and Ayurvedic treatment approaches, highlighting its differentiation from khalitya, where hair loss is more gradual.

This case study reports successful treatment of alopecia areata in a 22-year-old woman using an Ayurvedic approach, including microneedling and herbal therapies, which improved her SALT score from 22% to 0% after one month.

In this case study, a 20-year-old male with alopecia areata experienced complete hair regrowth and symptom relief without recurrence after Ayurvedic Shodhana and Shamana therapy, suggesting Ayurvedic treatments may offer a comprehensive approach to managing this condition.

This article discusses the characteristics of alopecia areata but reports no new research results.

This source examines alopecia areata, an autoimmune condition causing patchy hair loss, describing the current reliance on corticosteroid injections despite their severe side effects, and explores Ayurvedic treatments identified as Shaman and Shodhan for managing an equivalent condition called Indralupta.

This study reviewed existing literature to provide comprehensive insights into diagnosing and managing alopecia areata, emphasizing the importance of understanding its classification, etiology, and the diverse treatment options available for improved patient care.

This case report described a 26-year-old female with alopecia areata experiencing patchy hair loss, who showed improvement over five months with an individualized homeopathic treatment.

This study explored the connections between Covid-19 and hair loss issues like telogen effluvium and alopecia areata, highlighting the virus's potential trigger effect and underscoring the importance of comprehensive post-Covid-19 treatment strategies that consider immune, psychological, and hair cycle factors.

This study reviewed 562 alopecia areata patients in Colombia, observing a higher prevalence in women and common use of steroid injections and topical minoxidil as treatments.

This case report describes a male child with alopecia areata and renal dysgenesis, highlighting a possible coincidental association that may require future genetic investigation.

This study found that Baricitinib significantly reduced hair loss and immune response in a mouse model of alopecia areata.

This source explores the association between alopecia areata and thyroid dysfunction, highlighting a particularly strong link with Hashimoto thyroiditis and hypothyroidism.

This chapter reviews alopecia areata treatments, highlighting factors like age and disease extent in choosing management strategies, but reports no new clinical findings.

This case report describes a 14-year-old girl with alopecia areata who experienced hair restoration following homeopathic treatment aimed at balancing her immune system over a 6-month follow-up.

This article discusses scalp dermatoscopy and home CI therapy as promising diagnostic and treatment options for alopecia areata but reports no new clinical results.

Micronutrient deficiencies might contribute to alopecia areata.

This case report documents the first known occurrence of alopecia areata in a patient with ectodermal dysplasia linked to a WNT10A mutation, suggesting potential shared genetic factors in hair loss pathways.

This case report describes how alopecia areata and Beau's lines resolved in a child following treatment for Kawasaki disease, suggesting these symptoms may be linked to the underlying autoimmune process.

This case report discusses alopecia syphilitica in a young Belgian man, notes that hair loss was his only symptom, and highlights the improvement following penicillin treatment.

A synthetic drug and a South American herb may help treat alopecia areata in Chinese men.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

This chapter discusses alopecia areata and reports no new findings; it reviews the efficacy of current treatments like corticosteroids, topical sensitizers, and minoxidil, noting the lack of a cure or preventive measures.

This study found that 88% phenol treatment significantly improved texture, pigmentation, and density of hair regrowth in alopecia areata patients over nine weeks, with 78% showing a good to excellent response.